Lee H, Lee YH, Kim SU, Kim HC (2021) Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol 19:2138–2147.e2110

Article  PubMed  Google Scholar 

Lin H, Zhang X, Li G, Wong GL, Wong VW (2021) Epidemiology and clinical outcomes of metabolic (dysfunction)-associated fatty liver disease. J Clin Transl Hepatol 9:972–982

PubMed  PubMed Central  Google Scholar 

Lim S, Kim JW, Targher G (2021) Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab 32:500–514

Article  CAS  PubMed  Google Scholar 

Tanase DM, Gosav EM, Costea CF et al (2020) The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res 2020:3920196

Article  PubMed  PubMed Central  Google Scholar 

Targher G, Byrne CD, Tilg H (2020) NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69:1691–1705

Article  CAS  PubMed  Google Scholar 

Simon TG, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF (2022) Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut 71:1867–1875

Article  PubMed  Google Scholar 

Abdelmalek MF (2021) Nonalcoholic fatty liver disease: another leap forward. Nat Rev Gastroenterol Hepatol 18:85–86

Article  PubMed  PubMed Central  Google Scholar 

Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023

Article  PubMed  Google Scholar 

Stefan N, Häring H-U, Cusi K (2019) Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol 7:313–324

Article  PubMed  Google Scholar 

Castera L, Friedrich-Rust M, Loomba R (2019) Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156:1264–1281 e1264

Article  PubMed  Google Scholar 

Makri E, Goulas A, Polyzos SA (2021) Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res 52:25–37

Article  CAS  PubMed  Google Scholar 

Powell EE, Wong VW, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397:2212–2224

Article  CAS  PubMed  Google Scholar 

Wong VW, Adams LA, de Ledinghen V, Wong GL, Sookoian S (2018) Noninvasive biomarkers in NAFLD and NASH—current progress and future promise. Nat Rev Gastroenterol Hepatol 15:461–478

Article  CAS  PubMed  Google Scholar 

Zhang YN, Fowler KJ, Hamilton G et al (2018) Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br J Radiol 91:20170959

Article  PubMed  PubMed Central  Google Scholar 

Artz NS, Hines CD, Brunner ST et al (2012) Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse. Invest Radiol 47:603–610

Article  PubMed  PubMed Central  Google Scholar 

Beck S, Jahn L, Deniffel D et al (2022) Iodine images in dual-energy CT: detection of hepatic steatosis by quantitative iodine concentration values. J Digit Imaging 35:1738–1747

Article  PubMed  PubMed Central  Google Scholar 

Rogier J, Roullet S, Cornelis F et al (2015) Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio. Liver Transpl 21:690–695

Article  PubMed  Google Scholar 

Pickhardt PJ, Hahn L, Munoz del Rio A, Park SH, Reeder SB, Said A (2014) Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. AJR Am J Roentgenol 202:752–758

Article  PubMed  Google Scholar 

Bae JC, Lee WY, Yoon KH et al (2015) Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial. Diabetes Care 38:1245–1252

Article  CAS  PubMed  Google Scholar 

Zhao XM, Wang M, Wu RZ et al (2018) Dual-layer spectral detector CT monoenergetic reconstruction improves image quality of non-contrast cerebral CT as compared with conventional single energy CT. Eur J Radiol 103:131–138

Article  PubMed  Google Scholar 

Bai X, Gao P, Zhang D et al (2020) Plaque burden assessment and attenuation measurement of carotid atherosclerotic plaque using virtual monoenergetic images in comparison to conventional polyenergetic images from dual-layer spectral detector CT. Eur J Radiol 132:109302

Article  PubMed  Google Scholar 

Albrecht MH, De Cecco CN, Schoepf UJ et al (2018) Dual-energy CT of the heart current and future status. Eur J Radiol 105:110–118

Article  PubMed  Google Scholar 

Zeng Y-R, Yang Q-H, Liu Q-Y et al (2019) Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma. World J Gastroenterol 25:1986–1996

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rassouli N, Etesami M, Dhanantwari A, Rajiah P (2017) Detector-based spectral CT with a novel dual-layer technology: principles and applications. Insights Imaging 8:589–598

Article  PubMed  PubMed Central  Google Scholar 

Zheng X, Ren Y, Phillips WT et al (2013) Assessment of hepatic fatty infiltration using spectral computed tomography imaging: a pilot study. J Comput Assist Tomogr 37:134–141

Article  PubMed  Google Scholar 

Molwitz I, Campbell GM, Yamamura J et al (2022) Fat quantification in dual-layer detector spectral computed tomography: experimental development and first in-patient validation. Invest Radiol 57:463–469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bossuyt, Reitsma PM, Bruns DE JB et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351:h5527

Article  PubMed  PubMed Central  Google Scholar 

Guo Z, Blake GM, Li K et al (2020) Liver fat content measurement with quantitative CT validated against MRI proton density fat fraction: a prospective study of 400 healthy volunteers. Radiology 294:89–97

Article  PubMed  Google Scholar 

Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging–estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425

Article  PubMed  Google Scholar 

Huang X, Gao S, Ma Y, Lu X, Jia Z, Hou Y (2020) The optimal monoenergetic spectral image level of coronary computed tomography (CT) angiography on a dual-layer spectral detector CT with half-dose contrast media. Quant Imaging Med Surg 10:592–603

Article  PubMed  PubMed Central  Google Scholar 

Jia Y, Xiao X, Sun Q, Jiang H (2018) CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology. Clin Radiol 73:1033–1040

Article  CAS  PubMed  Google Scholar 

Deniffel D, Sauter A, Fingerle A, Rummeny EJ, Makowski MR, Pfeiffer D (2021) Improved differentiation between primary lung cancer and pulmonary metastasis by combining dual-energy CT-derived biomarkers with conventional CT attenuation. Eur Radiol 31:1002–1010

Article  PubMed